Health Wire East Timor: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Wire East Timor.

January 2026

Mo	Tu	We	Th	Fr	Sa	Su
			1	2	3	4
5	6	7	8	9	10	11
12	13	14	15	16	17	18
19	20	21	22	23	24	25
26	27	28	29	30	31

February 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28

March 2026

Mo	Tu	We	Th	Fr	Sa	Su
						1
2	3	4	5	6	7	8
9	10	11	12	13	14	15
16	17	18	19	20	21	22
23	24	25	26	27	28	29
30	31

Press releases published on February 3, 2026

Feb. 3, 2026

Oragenics Partners with DUCK FLATS Pharma to Support FDA IND Readiness and Clinical Trial Design for Concussion Program

GlobeNewswire

Feb. 3, 2026

GT Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for GTB-5550 TriKE®, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors Expressing B7-H3

GlobeNewswire

Feb. 3, 2026

HOOKIPA Pharma Announces Sale of Oncology Assets to NeoTrail Therapeutics

GlobeNewswire

Feb. 3, 2026

Polaryx to Present Late-Breaker Data Related to SOTERIA at the 22nd Annual WORLDSymposium™ as Company Prepares for SOTERIA Trial Launch

GlobeNewswire

Feb. 3, 2026

Vivos Inc Updates Human Therapy Progress in India

GlobeNewswire

Feb. 3, 2026

Gentherm Announces FDA 510(k) Submission for Innovative Technology Expected to Promote Safer Surgeries and Better Patient Outcomes

GlobeNewswire

Feb. 3, 2026

Ardelyx Receives New Patent for Tenapanor

GlobeNewswire

Feb. 3, 2026

Caring Brands Secures Two New U.S. Patents Strengthening Hair Enzyme Booster Technology

GlobeNewswire

Feb. 3, 2026

Nanox Receives FDA 510(k) Clearance for TAP2D New Image Enhancement Capability for Nanox.ARC and Nanox.ARC X Systems

GlobeNewswire

Feb. 3, 2026

SCIENTURE Provides Commercial Update on ARBLI™, the First FDA-Approved Ready-to-Use Oral Suspension of Losartan Potassium

GlobeNewswire

Feb. 3, 2026

Allarity Therapeutics announces that its collaborative Phase 2 trial with the United States Veteran’s Administration Combining Stenoparib with Temozolomide in Relapsed Small Cell Lung Cancer is Now Open for Enrollment

GlobeNewswire

Feb. 3, 2026

Theriva™ Biologics Announces Upcoming Presentation of Data from VCN-01 Retinoblastoma Phase 1 Clinical Trial at APAO 2026

GlobeNewswire

Feb. 3, 2026

Theriva™ Biologics anuncia la próxima presentación de los datos del ensayo clínico de Fase 1 del VCN-01 para el retinoblastoma en el Congreso de la Academia de Oftalmología de Asia-Pacífico (APAO) de 2026

GlobeNewswire

Feb. 3, 2026

Byonyks X1: Revolutinizing Dialysis - Now FDA Cleared and Planning to start Patients in the U.S.

GlobeNewswire

Feb. 3, 2026

Beghou Names Meredith Ressi as President and Chief Growth Officer

GlobeNewswire

Feb. 3, 2026

Kyverna Therapeutics Appoints Mayo Pujols as Chief Technology Officer

GlobeNewswire

Feb. 3, 2026

aTyr Pharma Announces Scheduling of FDA Type C Meeting to Discuss Efzofitimod Program in Pulmonary Sarcoidosis

GlobeNewswire

Feb. 3, 2026

IN8bio to Present at Upcoming Investor and Scientific Conferences in February

GlobeNewswire

Feb. 3, 2026

Amicus Therapeutics Presents New Long-term Data for both Galafold® (migalastat) and POMBILITI® (cipaglucosidase alfa-atga) + OPFOLDA® (miglustat) at the 22nd Annual WORLDSymposium™ 2026

GlobeNewswire

Feb. 3, 2026

Mesa Labs Announces Third Quarter Results

GlobeNewswire